Stryker Corporation (SYK)

NYSE: SYK · USD

$337

+6.51 (+2.0%)· Recorded snapshot

Coverage state: Latest published research available

Market snapshot recorded 2026-07-28 02:00 UTC. Latest published research analyzed 2026-05-12 · stale · sources unverified. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate a fresh SYK analysis

The published report stays available while a new owner-requested analysis runs.

StockMarketAgent Research · Analyzed 2026-05-12

Our latest published analysis: SYK rated Hold

Hold. The current valuation fully prices in the high-quality compounding nature and Mako robotics growth.

Fair value (mid)

$297 / share

$225 – $370

Upside to FV

+1.0%

from $337

Confidence

88/100

Moat

9/10

Read full analysis

Market cap	$112.8B
Revenue (ttm)	25.3B
Net income (ttm)	3.3B
EPS (ttm)	$8.64
Shares out	383.4M
P/E (trailing)	39.0x
P/E (forward)	17.6x
Dividend	$3.52 (1.04%)
Volume	2,069,975
Beta	0.78
Price target	$387	+14.8%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 25.3B
Net income (ttm): 3.3B
EPS (ttm): $8.64
P/E (trailing): 39.0x
P/E (forward): 17.6x
Market cap: $112.8B

Item	P1	P2	P3	P4	Trend
Period	2022-12-31	2023-12-31	2024-12-31	2025-12-31	Trend
Revenue	$18.45B	$20.50B	$22.60B	$25.12B	+10.8%
Gross profit	$11.58B	$13.06B	$14.44B	$16.07B	+11.5%
Operating income	$3.11B	$3.92B	$4.67B	$5.06B	+17.6%
Net income	$2.36B	$3.17B	$2.99B	$3.25B	+11.2%
EPS (diluted)	$6.17	$8.25	$7.76	$8.40	+10.8%
EBITDA	$4.11B	$5.06B	$4.95B	$6.31B	+15.4%
R&D	$1.45B	$1.39B	$1.47B	$1.62B	+3.7%
SG&A	$6.39B	$7.11B	$7.69B	$8.65B	+10.6%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AAPL	Apple Inc.	5T	41.0x	11.0x	104.3%	+6.8%	+58.6%	Sell
ABNB	Airbnb Inc.	90.8B	37.5x	7.2x	15.9%	+29.9%	+7.6%	Hold
ADBE	Adobe Inc.	104.7B	15.1x	4.2x	60.7%	+11.9%	-28.7%	Strong Buy
ABBV	AbbVie Inc.	465.2B	129.7x	7.4x	14.4%	+4.6%	+44.0%	Hold
ABT	Abbott Laboratories	186.9B	34.9x	4.0x	7.9%	+3.0%	-12.5%	Strong Buy
AMGN	Amgen Inc.	209.2B	27.0x	5.6x	19.1%	+8.1%	+32.5%	Strong Buy

All SYK indicators

Market & fundamental data

Available fields

292

Groups with data

Currency

USD

Showing 292 of 292 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000310764
Company name	Stryker Corporation
Country	United States
Country code	US
Cusip	863667101
Employees	56,000
Employees Change	3,000%
Employees Change Percent	5.66
Enterprise value	$141.4B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
In Index	SP500
Industry	Medical Devices
Industry PE	41.22
Industry PE Fwd	19.05
Isin	US8636671013
Last refreshed	2026-07-28
Market cap	$129.1B
Market cap category	Large-Cap
Price	$337
Price currency	USD
Rev Per Employee	451,250x
Sector	Healthcare
Sector PE	45.29
Sector PE Fwd	23.97
Sic	3841
Symbol	SYK
Website	https://www.stryker.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.58%
EV Earnings	42.36x
EV Sales Forward	5.05x
EV/EBIT	28.34x
EV/EBITDA	22.77x
EV/FCF	30.93x
EV/Sales	5.59x
FCF yield	3.54%
Forward P/E	21.45x
P/B ratio	5.62x
P/E ratio	38.98x
P/S ratio	5.11x
PE Ratio10 Y	40.38x
PE Ratio3 Y	42.48x
PE Ratio5 Y	42.88x
PEG ratio	2x
PS Forward	4.61x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	19.74%
EBITDA Margin	24.57%
FCF margin	18.09%
Gross margin	64.7%
Gross Profit	$16.3B
Gross Profit Growth	8.83%
Gross Profit Growth Q	0.34%
Gross Profit Growth3 Y	11.1%
Gross Profit Growth5 Y	11.7%
Net Income	$3.3B
Net Income Growth	16.72%
Net Income Growth Q	13.91%
Net Income Growth Quarters	4%
Net Income Growth Years	1%
Net Income Growth3 Y	8.3%
Net Income Growth5 Y	18.84%
Pretax Margin	18.2%
Profit Margin	13.21%
Profit Per Employee	$59,589
Profitable Quarters	$23
Profitable Years	35
ROA	7.72
Roa5y	6.99
ROCE	12.48
ROE	15.2
Roe5y	15.51
ROIC	11.82
Roic5y	12.85

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	12.44%
Cagr15y	14.24%
Cagr1y	-15.71%
Cagr20y	11.84%
Cagr3y	6.12%
Cagr5y	6.12%
Div CAGR10	8.89%
Div CAGR3	5.72%
Div CAGR5	7.14%
EPS Growth	16.76
EPS Growth Q	14.2
EPS Growth Quarters	4
EPS Growth Years	1
EPS Growth3 Y	7.94
EPS Growth5 Y	18.55
FCF Growth	27.79%
FCF Growth Q	226.77%
FCF Growth3 Y	26.33%
FCF Growth5 Y	11.01%
OCF Growth	25.35%
OCF Growth Q	132.4%
OCF Growth10 Y	21.28%
OCF Growth3 Y	23.32%
OCF Growth5 Y	11.36%
Revenue Growth	8.84x
Revenue Growth Q	2.63x
Revenue Growth Quarters	23x
Revenue Growth Years	5x
Revenue Growth3 Y	10.07x
Revenue Growth5 Y	11.42x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.55
Assets	$46.3B
Cash	$3B
Current Assets	$13.3B
Current Liabilities	$6.3B
Debt	$15.2B
Debt EBITDA	$2.45
Debt Equity	$0.66
Debt FCF	$3.33
Equity	$23B
Interest Coverage	8.02
Liabilities	$23.3B
Long Term Assets	$33B
Long Term Liabilities	$17B
Net Cash	$-12.3B
Net Cash By Market Cap	$-9.5
Net Debt EBITDA	$1.98
Net Debt Equity	$0.53
Net Debt FCF	$2.68
Tangible Book Value	$-1.7B
Tangible Book Value Per Share	$-4.5
WACC	7.94

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.11
Inventory Turnover	1.7
Net Working Capital	$4.7B
Quick ratio	1.04
Working Capital	$7B
Working Capital Turnover	$4.17

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.16%
Dividend Growth	4.82%
Dividend Growth Years	16%
Dividend per share	$3.52
Dividend Years	36
Dividend Yield	1.05%
Ex Div Date	2026-06-30
Last Dividend	$0.88
Payout Frequency	Quarterly
Payout Ratio	40.28%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	222.99%
1Y total return	-15.7%
200-day SMA	343.7
3Y total return	19.52%
50-day SMA	314.6
50-day SMA vs 200-day SMA	50under200
5Y total return	34.59%
All Time High	406.2
All Time High Change	-17.1%
All Time High Date	2025-01-28
All Time Low	0.26
All Time Low Change	129,216.44%
All Time Low Date	1984-06-08
ATR	10.35
Beta	0.78
Beta1y	0.41
Beta2y	0.56
Ch YTD	-4.19
High	338.8
High52	404.1
High52 Date	2025-07-28
High52ch	-16.68%
Low	331.9
Low52	281
Low52 Date	2026-05-11
Low52ch	19.84%
Ma50ch	7.04%
Premarket Change Percent	0.37
Premarket Price	$331
Premarket Volume	2,892
Price vs 200-day SMA	-2.02%
RSI	59.25
RSI Monthly	48.26
RSI Weekly	51.08
Sharpe ratio	-0.6x
Sortino ratio	-0.63
Total Return	0.89%
Tr YTD	-3.68
Tr15y	637.03%
Tr1m	1.48%
Tr1w	5.52%
Tr3m	3.09%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	27
Analyst Count Top	9
Analyst Price Target Top	$385
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$3.49
Earnings EPS Estimate Growth	11.5
Earnings Revenue Estimate	6,574,994,464x
Earnings Revenue Estimate Growth	9.18x
Operating Income	$5.7B
Operating Income Growth	11.38
Operating Income Growth Q	-5.21
Operating Income Growth3 Y	16.16
Operating Income Growth5 Y	14.07
Operating margin	22.54
Price target	$387
Price Target Change	$14.78
Price Target Change Top	$14.44

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	347,568,181%
Float Percent	90.66%
Net Borrowing	-2,400,000,000
Shares Insiders	9.24%
Shares Institutions	81.01%
Shares Out	383,360,762
Shares Qo Q	0%
Shares Yo Y	0.16%
Short Float	2.02%
Short Ratio	2.55
Short Shares	1.83

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$4.3B
Adjusted OCF	5,129,000,000
Average Volume	2,359,437.55x
Bv Per Share	59.94
CAPEX	$-804M
Ch10y	189.2
Ch15y	510.9
Ch1m	1.21
Ch1w	5.52
Ch1y	-16.55
Ch20y	645.2
Ch3m	2.82
Ch3y	16.07
Ch5y	27.78
Ch6m	-5.67
Change	1.97%
Change From Open	1.18
Close	330.3
Days Gap	0.78
Depreciation Amortization	1,221,000,000
Dollar Volume	697,043,381.5
Earnings Date	2026-07-30
Earnings Time	amc
EBIT	$5B
EBITDA	$6.2B
EPS	$8.64
F Score	7
FCF	$4.6B
FCF EV Yield	3.23x
FCF Per Share	$11.92
Financing CF	-3,931,000,000
Fiscal Year End	December
Founded	1,941
Goodwill	19,188,000,000
Graham Number	107.94606
Graham Upside	-67.94
Income Tax	$1.3B
Investing CF	-915,000,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Last Split Date	2004-05-17
Last Split Type	Forward
Last10k Filing Date	2026-02-11
Lynch Fair Value	$163
Lynch Upside	-51.67
Ma150	336.3
Ma150ch	0.14%
Ma20	323.1
Ma20ch	4.21%
Net CF	558,000,000
Next Earnings Date	2026-07-30
Open	332.8
Optionable	Yes
P FCF Ratio	28.24
P FCF Ratio SBC	29.85
P OCF Ratio	24.02
P OCF Ratio SBC	25.17
Payment Date	2026-07-31
Position In Range	70.16
Post Close	336.7
Postmarket Change Percent	0.15
Postmarket Price	$337
Ppne	4,416,000,000
Pre Close	330.3
Price Date	2026-07-27
Price EBITDA	$20.79
Relative Volume	0.88x
Revenue	25,270,000,000x
SBC By Revenue	0.97x
Share Based Comp	246,000,000
Tax By Revenue	5x
Tax Rate	27.46%
Tr20y	837.05%
Tr6m	-5.16%
Us State	Michigan
Volume	2,069,975
Z Score	5.42

Frequently asked questions

About this SYK report

What is the latest published SYK stock rating?

Stryker Corporation is shown with hold in the latest published report, analyzed 2026-05-12. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full SYK analysis?

The full latest published report, analyzed 2026-05-12, lives at /stocks/SYK/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair-value range is used for SYK?

The latest published report analyzed 2026-05-12 frames SYK around USD 225 to USD 370. This is a dated valuation range, not a live market price; check the valuation, sensitivity, and bear-case tabs before making a decision.

How often is the SYK page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-05-12). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

Stryker Corporation (SYK)

Coverage state: Latest published research available

Generate a fresh SYK analysis

Our latest published analysis: SYK rated Hold

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · SYK

Valuation

Profitability

Balance sheet

Trading

Position sizing & entry playbook

Next earnings

Sector percentile context

All SYK indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on SYK

Frequently asked questions